MARPE Failure at the Suture
Versus
the Screw: Two Failure Modes Apart
Differentiate skeletal suture resistance from miniscrew loosening. Age-sex-dependent outcomes and load protocols determine success.
TL;DR MARPE failure occurs via two independent mechanisms: midpalatal suture non-separation (failure at the skeletal interface) and miniscrew loosening (failure at the device interface). Success depends on patient age, bone density, and screw design. Sex-dependent outcomes and proper load management predict clinical outcomes.
Miniscrew-assisted rapid palatal expansion has transformed treatment options for adult patients with transverse deficiency, yet clinicians frequently encounter two mechanically distinct failure modes during therapy. In this article, Dr. Mark Radzhabov examines MARPE failure at the suture versus the screw—clarifying why certain cases show successful skeletal response despite device loosening, and why others fail to separate the midpalatal suture despite adequate miniscrew stability. Drawing on contemporary clinical evidence and more than a decade of practice, this analysis provides decision-ready criteria to differentiate failure mechanisms, predict outcomes based on patient age and sex, and implement protocol adjustments before catastrophic device loss occurs.
What Is MARPE Failure: Suture vs. Screw
Failure
MARPE failure at the suture represents a skeletal problem: the midpalatal suture remains fused or interdigitated despite adequate force application, preventing maxillary basal bone separation. Failure at the screw represents a device problem: the miniscrew loses retention or fractures before skeletal response occurs, ending therapy prematurely. These are independent failure modes. A patient may show excellent screw stability yet no suture separation. Conversely, a case may demonstrate robust suture opening while the screw loosens from reactive bone loss. Distinguishing between them requires pretreatment assessment (age, sex, bone density, suture morphology) and intratreatment monitoring (periapical radiographs, screw torque measurements, midline diastema progression). Clinical outcomes reported in a prospective randomized trial showed midpalatal suture separation rates of 90–95% when treated to identical expansion turns, but the amount of skeletal separation and screw stability varied significantly by age and sex. Understanding which failure mode threatens your specific patient allows you to modify load protocols, screw design selection, or timing of therapy before the case is lost.
Failure at the Suture: Age- and Sex-Dependent
Resistance
Midpalatal suture non-separation is the more common MARPE failure mode and is strongly age and sex dependent. Recent clinical analysis of 215 MARPE patients across a 6–60 year age range revealed dramatic differences: suture separation success was 94.17% in female patients but only 61.05% in male patients overall. In males, suture separation success declined steeply with age. Patients over 30 showed substantially lower separation rates and reduced basal bone expansion compared to adolescents. In females, the relationship was less pronounced, with successful separation maintained even into the third decade in many cases. When suture separation did occur, the amount of skeletal opening was significantly less in older patients (both sexes), suggesting that interdigitation density and sutural rigidity increase over time. The resistance at the suture is a biological constraint, not a device failure—the miniscrew remains secure, but the skeleton does not respond. Clinically, this means older male patients carry elevated risk for suture non-separation despite adequate screw torque and force application. Pretreatment CBCT analysis of sutural morphology, fusion patterns, and bone density in the palatal complex can help predict which patients will encounter skeletal resistance versus those likely to respond.
Failure at the Screw: Miniscrew Loosening and
Instability
Mechanisms
Miniscrew loosening and loss occur through several mechanical pathways distinct from skeletal resistance. Excessive early-stage force (>200 g initial load or >4 turns per day for the first 10 days) can trigger cortical resorption around the screw threads, reducing primary stability and leading to progressive micro-motion and bone loss. Improper screw angulation (insufficient parallelism to the median plane or excessive buccal tilt) concentrates shear stress at the cortical interface, accelerating thread loosening. Screw design factors—thread pitch, core diameter, and surface treatment—affect bone response. Smaller diameter screws in low-density palatal bone show higher loosening rates than larger-diameter systems with optimized thread geometry. Reactive bone loss occurs more aggressively in patients with lower baseline bone density or those with delayed consolidation periods (premature device removal before 6 months of retention). Unlike suture resistance, which is a skeletal pattern, screw loosening is detectable and often preventable: monthly torque checks using a torque gauge, periapical radiographs to assess bone density around threads, and adjustment of activation protocol (reducing daily turns to 2–3 after the first 10 days) can preserve device stability. Clinical observation suggests that screw failure is more common in the first 3 months of therapy, whereas suture resistance becomes apparent after 6–8 weeks of adequate activation.
Diagnosing Failure Mode: Clinical and Radiographic
Signs
Distinguishing suture failure from screw failure requires systematic assessment at multiple time points. At activation visit (week 2–3): assess midline diastema progression (indicates suture opening has begun), screw thread visibility on periapical radiograph (widening gaps = stable threads. Collapse = loosening), and screw torque measurement (>10 Ncm = adequate; <8 Ncm = concerning). At consolidation assessment (week 6–8): measure midpalatal suture separation on periapical radiograph using the medial interradicular distance of the maxillary central incisors as a proxy. Separation ≥3 mm indicates successful skeletal response. Compare pre- and post-activation screw angulation on periapical films. Unchanged angulation suggests screw has not migrated. If midline diastema is present but periapical radiograph shows no suture separation and screw threads appear intact, the opening is dental tipping (alveolar, not skeletal), and the case will relapse. If no diastema appears AND screw torque is <8 Ncm with radiographic thread collapse, the failure is device loss. If diastema appears but screw loosens simultaneously (declining torque + thread visibility loss), prioritize immediate consolidation (halt activation, establish 3-month retention phase) to preserve whatever skeletal gain occurred before catastrophic screw loss. CBCT imaging at baseline identifies patients at high risk for either failure mode: narrow, dense, heavily interdigitated sutures predict suture resistance. Low-density palatal cortex predicts screw loosening.
Load-Staged Activation: Preventing Screw Failure While
Maximizing
Skeletal Response
Optimized load-staged activation protocols reduce both failure modes. Week 1 (day of insertion through day 3–4): apply gentle initial activation—4 turns on day of placement, then 1–2 day rest. Week 1–2: resume at 3 turns per day for 7–10 days to allow initial cortical response and screw primary stability consolidation without overload. Week 2 onward: advance to 2–3 turns per day as the new protocol standard, maintaining this rate throughout the 8–12 week active expansion phase. The rationale: excessive early force (≥4 turns daily from day 1) triggers immediate cortical resorption and bone loss around threads, destabilizing the screw interface before skeletal suture resistance is fully engaged. Conservative early loading allows the screw to become osseointegrated into palatal bone while the skeletal system begins to respond. For patients at high risk of suture non-separation (males >25 years, pre-CBCT evidence of sutural fusion), some clinicians employ adjunctive corticotomy or laser cortication (light pulsed near the suture) to reduce interdigitation density, although evidence for this approach remains limited. Periodically reassess during therapy: if suture separation is evident but screw is loosening (declining monthly torque), enter consolidation phase early (typically week 8–10) rather than continuing to the planned 12 weeks. If suture separation is absent at week 10 despite stable screw, consider surgical assistance (SARPE) rather than prolonging mechanical therapy. This differentiated approach acknowledges that the two failure modes require different solutions: screw loosening is managed by load reduction and stability monitoring. Suture resistance is managed by extending therapy or escalating to surgery.
Managing Active MARPE Failure: When to Persist,
Adjust
or Escalate
When MARPE performance declines, a structured decision algorithm based on failure mode prevents wasted time and clinical frustration. Scenario 1—Midline diastema present, screw stable (torque >10 Ncm), suture separation evident on radiograph: continue therapy as planned. Increase consolidation period to 5–6 months if bone density appears low around screw threads. Scenario 2—No midline diastema, suture separation absent at week 8, screw remains stable: this is pure suture resistance. At this point, a CBCT assessment determines next steps. If sutural fusion is radiographically confirmed, discontinue mechanical expansion and either refer for SARPE or manage the transverse deficiency with orthodontic compensation (posterior crossbite correction via buccal root torque, if esthetically acceptable). Continuing mechanical therapy beyond 10–12 weeks in the face of confirmed suture non-separation increases the risk of screw loosening without skeletal gain. Scenario 3—Midline diastema present but declining, screw loosening (monthly torque drop >2 Ncm), radiograph shows screw thread collapse: this is device failure with concurrent skeletal response. Immediately halt further activation. Lock the screw at current position. Establish a 6-month consolidation phase with the device in place to ossify whatever skeletal separation has occurred. Plan delayed removal after consolidation. If skeletal separation is minimal (midline diastema <4 mm), discuss with patient whether the preliminary gain justifies consolidation or if SARPE is preferable. Scenario 4—No diastema, screw loosens, suture remains fused: device failure with no skeletal benefit. Remove the appliance, refer for SARPE if clinical indication persists. These scenarios underscore that age, sex, bone quality, and screw design all contribute to which failure mode dominates. Dr. Mark Radzhabov emphasizes that pretreatment patient selection—particularly excluding males >35 years with radiographic evidence of sutural fusion—and protocol adherence prevent many preventable failures.
Learn the full MARPE protocol from Dr. Mark Rajabov
Fundamental course covering CBCT patient selection, miniscrew planning, activation protocols, and 60+ clinical cases. Choose the access level that fits your practice.
Essentials of rapid palatal expansion for practicing orthodontists.
- Core RPE concepts and biomechanics
- 6 structured video lessons
- Clinical decision checklists
- Lifetime access to recordings
Deep-dive into MARPE protocol, diagnostics, and clinical execution.
- 6 modules covering MARPE from A to Z
- CBCT case selection walkthroughs
- Miniscrew placement and activation
- 60+ annotated clinical cases
- Direct Q&A with Dr. Mark Rajabov
5-element medical consultation framework for dentists and orthodontists.
- Trust-building consultation protocol
- 5 lesson modules
- Templates for treatment plan delivery
- Works with any clinical specialty
Clinical FAQ
What is the difference between MARPE failure at the suture versus at the screw?
Suture failure is skeletal non-separation despite adequate miniscrew stability. The midpalatal suture remains fused or resists opening. Screw failure is device loosening or fracture before skeletal response completes. Suture failure is age- and sex-dependent. Screw failure is load-related and preventable via protocol and torque monitoring.
How does patient sex affect MARPE success rate for suture separation?
Female patients achieve 94.17% suture separation success, while males achieve only 61.05%. This difference increases with age. Older males show the greatest risk of suture non-separation. Female patients maintain higher success rates even into the third decade, making sex an important risk stratification variable.
At what age does MARPE suture separation success decline most significantly?
Statistically significant decline occurs after age 25–30, with steeper declines in males. Patients over 35 show substantially reduced separation and minimal skeletal expansion amounts. Pretreatment patient selection should strongly consider age and baseline sutural morphology on CBCT.
How does the load-staged activation protocol reduce miniscrew loosening?
Load-staged activation (4 turns day 1, 3 turns/day for 10 days, then 2–3 turns/day) minimizes early cortical resorption and allows screw osseointegration before peak mechanical stress. Excessive early force triggers immediate bone loss around threads, destabilizing the screw interface prematurely.
What screw torque value indicates miniscrew loosening in MARPE?
Monthly torque >10 Ncm indicates stability; 8–10 Ncm is marginal; <8 Ncm signals concerning loosening. A monthly decline >2 Ncm from baseline warrants protocol adjustment—halt activation, enter consolidation phase, plan removal.
How can I distinguish suture non-separation from miniscrew loosening using clinical signs?
Measure midline diastema (absence with stable screw = alveolar tipping only), screw torque (declining = loosening), and periapical radiograph for suture separation (present = skeletal response. Absent = suture resistance). These three assessments together differentiate failure modes reliably.
Should I continue MARPE if suture separation is absent by week 10 but the screw is stable?
No. Absence of suture separation by week 8–10 despite stable screw indicates irreversible suture resistance. Continuing beyond this point increases screw loosening risk without skeletal benefit. Consider SARPE referral or orthodontic compensation instead.
What is the optimal consolidation period for MARPE after active expansion ends?
Standard consolidation is 3–6 months with the device locked in final position. Extend to 6 months if bone density around screw appears low on radiograph or if screw is showing early loosening signs. This allows ossification of skeletal gains before removal.
Can pretreatment CBCT predict whether a patient will have suture non-separation or screw loosening?
Partially. CBCT shows sutural fusion density and morphology (predicts suture resistance), palatal cortical thickness (predicts screw stability risk), and bone density (guides force protocol). Combine CBCT findings with patient age and sex for best risk stratification.
How should I modify MARPE protocol if the patient is a male over 30 years old with low bone density?
Reduce daily activation to 2–3 turns (skip the standard 4-turn day 1 and 3-turn/day phase). Obtain baseline and monthly torque measurements. Plan 6-month consolidation. Accept lower skeletal gains and discuss SARPE as alternative if clinical need is high.
Recognizing whether MARPE failure stems from suture resistance or screw instability fundamentally changes your clinical response. Age-dependent suture patterns, sex-specific bone remodeling, and screw design all predict which failure mode you will encounter. Dr. Mark Radzhabov advocates for pretreatment radiographic assessment, load-stage protocols, and proactive screw monitoring to maximize skeletal gains while preserving device integrity. If you are managing complex adult expansion cases or wish to refine your MARPE protocol, review your last five cases for these failure signatures and consider a consultation to discuss optimization strategies.
